Results 61 to 70 of about 13,080 (176)

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade

open access: yesJournal for ImmunoTherapy of Cancer
Background Antibodies that target immune checkpoints such as cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein/ligand 1 (PD-1/PD-L1) are approved for treatment of multiple cancer types.
Elly Marcq   +14 more
doaj   +1 more source

SIRT Family: Biological Functions and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 8, August 2026.
SIRT1–SIRT7 networks from transgenic mice to human‑relevant therapeutic targets. SIRT1–SIRT7 form an isoform‑, organ‑, and disease‑specific regulatory network. Transgenic Sirt1–7 mouse models define central regulatory SIRTs (SIRT1, SIRT3, SIRT6), context‑dependent modifiers (SIRT2, SIRT4, SIRT5, SIRT7), and their key mechanisms and target organs. These
Jia‐Yi Wang   +9 more
wiley   +1 more source

e-Toolkit for the Elimination of Asbestos-Related Diseases in Developing Countries

open access: yesSafety and Health at Work, 2022
Ken Takahashi, Kim Brislan
doaj   +1 more source

The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop

open access: yesFrontiers in Toxicology
Objectives: This study combines two innovative mouse models in a major gene discovery project to assess the influence of host genetics on asbestos related disease (ARD).
Scott A. Fisher   +26 more
doaj   +1 more source

Prospective study of asbestos-related diseases incidence cases in primary health care in an area of Barcelona province

open access: yesBMC Public Health, 2010
Background Asbestos related diseases include a number of conditions due to inhalation of asbestos fibres at work, at home or in the environment, such as pleural mesothelioma, asbestosis and calcified pleural plaques.
Orriols Ramon   +9 more
doaj   +1 more source

Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines

open access: yesThoracic Cancer, Volume 17, Issue 15, August 2026.
Three novel malignant pleural mesothelioma (MPM) cell lines (PUMC‐MESO1, PUMC‐MESO3, and PUMC‐MESO4) were established from patient‐derived pleural effusions. All three cell lines expressed mesothelioma markers (calretinin, WT1, and D2‐40) and showed BAP1 loss of expression.
Yani Wu   +7 more
wiley   +1 more source

Assessment of a feed additive consisting of montmorillonite‐illite mixed layer clay mineral (1g557) for all animal species for the renewal of its authorisation (FIM Biotech GmbH)

open access: yesEFSA Journal, Volume 24, Issue 8, August 2026.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the renewal of montmorillonite‐illite mixed layer clay mineral as a technological feed additive for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of ...
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +21 more
wiley   +1 more source

Asbestos and Asbestos-related Diseases in Vietnam: In reference to the International Labor Organization/World Health Organization National Asbestos Profile

open access: yesSafety and Health at Work, 2013
This paper describes progress on formulating a national asbestos profile for the country of Vietnam. The Center of Asbestos Resource, Vietnam, formulated a National Profile on Asbestos-related Occupational Health, with due reference to the International ...
Van Hai Pham   +7 more
doaj   +1 more source

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

open access: yesInternational Journal of Cancer, Volume 159, Issue 2, Page 410-422, 15 July 2026.
What's new? Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor to multiple myeloma, sharing substantial genetic features with overt malignancy. Given evidence implicating autophagy in myeloma risk, this study examined whether genetic variations in autophagy‐related genes influence MGUS susceptibility.
José Manuel Sánchez‐Maldonado   +54 more
wiley   +1 more source

Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes

open access: yesOncoImmunology
Immune checkpoint therapy (ICT) causes durable tumour responses in a subgroup of patients, but it is not well known how T cell receptor beta (TCRβ) repertoire dynamics contribute to the therapeutic response.
Joel Kidman   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy